Samsung Biologics (Korea) Price Prediction

207940 Stock   934,000  2,000  0.21%   
As of today, The value of RSI of Samsung Biologics' share price is at 57. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Samsung Biologics, making its price go up or down.

Oversold Vs Overbought

57

 
Oversold
 
Overbought
The successful prediction of Samsung Biologics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Samsung Biologics Co, which may create opportunities for some arbitrage if properly timed.
Using Samsung Biologics hype-based prediction, you can estimate the value of Samsung Biologics Co from the perspective of Samsung Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Samsung Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying Samsung because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Samsung Biologics after-hype prediction price

    
  KRW 934000.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Samsung Biologics Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
933,999934,000934,001
Details
Naive
Forecast
LowNextHigh
900,413900,415900,416
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
929,904984,4171,038,929
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Samsung Biologics. Your research has to be compared to or analyzed against Samsung Biologics' peers to derive any actionable benefits. When done correctly, Samsung Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Samsung Biologics.

Samsung Biologics After-Hype Price Prediction Density Analysis

As far as predicting the price of Samsung Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Samsung Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Samsung Biologics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Samsung Biologics Estimiated After-Hype Price Volatility

In the context of predicting Samsung Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Samsung Biologics' historical news coverage. Samsung Biologics' after-hype downside and upside margins for the prediction period are 933,999 and 934,001, respectively. We have considered Samsung Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
934,000
933,999
Downside
934,000
After-hype Price
934,001
Upside
Samsung Biologics is very steady at this time. Analysis and calculation of next after-hype price of Samsung Biologics is based on 3 months time horizon.

Samsung Biologics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Samsung Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Samsung Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Samsung Biologics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.04 
1.30
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
934,000
934,000
0.00 
0.00  
Notes

Samsung Biologics Hype Timeline

Samsung Biologics is presently traded for 934,000on Korea Stock Exchange of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Samsung is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.04%. %. The volatility of related hype on Samsung Biologics is about 0.0%, with the expected price after the next announcement by competition of 934,000. About 75.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 2417.83. Samsung Biologics had not issued any dividends in recent years. The entity had 476:471 split on the 28th of February 2022. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days.
Check out Samsung Biologics Basic Forecasting Models to cross-verify your projections.

Samsung Biologics Related Hype Analysis

Having access to credible news sources related to Samsung Biologics' direct competition is more important than ever and may enhance your ability to predict Samsung Biologics' future price movements. Getting to know how Samsung Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Samsung Biologics may potentially react to the hype associated with one of its peers.

Samsung Biologics Additional Predictive Modules

Most predictive techniques to examine Samsung price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Samsung using various technical indicators. When you analyze Samsung charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Samsung Biologics Predictive Indicators

The successful prediction of Samsung Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Samsung Biologics Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Samsung Biologics based on analysis of Samsung Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Samsung Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Samsung Biologics's related companies.

Story Coverage note for Samsung Biologics

The number of cover stories for Samsung Biologics depends on current market conditions and Samsung Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Samsung Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Samsung Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Samsung Biologics Short Properties

Samsung Biologics' future price predictability will typically decrease when Samsung Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Samsung Biologics Co often depends not only on the future outlook of the potential Samsung Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Samsung Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding66.9 M

Complementary Tools for Samsung Stock analysis

When running Samsung Biologics' price analysis, check to measure Samsung Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Samsung Biologics is operating at the current time. Most of Samsung Biologics' value examination focuses on studying past and present price action to predict the probability of Samsung Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Samsung Biologics' price. Additionally, you may evaluate how the addition of Samsung Biologics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
CEOs Directory
Screen CEOs from public companies around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated